Valuation China Biotech Services Holdings Limited
Stocks
8037
BMG2152F1014
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7100 HKD | +4.41% |
|
+4.41% | -10.13% |
| 05-18 | China Biotech Services' unit disposes entire stake in PHC Medical Diagnostic Centre, others | RE |
| 04-30 | China Biotech Services says He Xun resigns as executive director | RE |
Company Valuation: China Biotech Services Holdings Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,256 | 1,329 | 1,108 | 741.7 | 497.6 | 770.8 |
| Change | - | 5.84% | -16.67% | -33.04% | -32.91% | 54.9% |
| Enterprise Value (EV) 1 | 976.4 | 1,244 | 1,097 | 770 | 666.5 | 1,154 |
| Change | - | 27.42% | -11.85% | -29.79% | -13.44% | 73.08% |
| P/E | 41.7x | 68.7x | 4.29x | -7.77x | -2.49x | -11.2x |
| PBR | 3.66x | 3.36x | 1.84x | 1.6x | 1.88x | 4.03x |
| PEG | - | -1.9x | 0x | 0x | -0x | 0.2x |
| Capitalization / Revenue | 1.92x | 2.13x | 0.6x | 3.5x | 7.06x | 10.5x |
| EV / Revenue | 1.49x | 1.99x | 0.59x | 3.63x | 9.45x | 15.7x |
| EV / EBITDA | 4.34x | 5.08x | 1.22x | -10.7x | -5.05x | -18.2x |
| EV / EBIT | 5x | 6.56x | 1.3x | -6.59x | -4.56x | -15.6x |
| EV / FCF | 3.88x | 49.2x | 5.83x | 14.3x | -183x | -7.19x |
| FCF Yield | 25.7% | 2.03% | 17.1% | 7% | -0.55% | -13.9% |
| Dividend per Share 2 | - | - | 0.01 | - | - | - |
| Rate of return | - | - | 0.87% | - | - | - |
| EPS 2 | 0.0312 | 0.0201 | 0.2679 | -0.0991 | -0.2046 | -0.0705 |
| Distribution rate | - | - | 3.73% | - | - | - |
| Net sales 1 | 655.8 | 623.8 | 1,852 | 212 | 70.51 | 73.5 |
| EBITDA 1 | 224.9 | 245 | 900.8 | -72.16 | -132.1 | -63.47 |
| EBIT 1 | 195.3 | 189.5 | 845.1 | -116.9 | -146.3 | -73.86 |
| Net income 1 | 30.17 | 19.38 | 258.1 | -95.45 | -198.1 | -68.78 |
| Net Debt 1 | -279.5 | -85.14 | -10.99 | 28.31 | 168.9 | 382.8 |
| Reference price 2 | 1.3000 | 1.3800 | 1.1500 | 0.7700 | 0.5100 | 0.7900 |
| Nbr of stocks (in thousands) | 966,046 | 963,231 | 963,231 | 963,231 | 975,731 | 975,731 |
| Announcement Date | 3/29/21 | 3/31/22 | 3/29/23 | 4/1/24 | 4/23/25 | 4/29/26 |
1HKD in Million2HKD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 84.64M | |
| 16.9x | 0.47x | 10.1x | 2.51% | 135B | |
| 12.65x | 1.66x | 8.22x | 0.82% | 84.04B | |
| 12.48x | 1.43x | 8.68x | 2.72% | 26.91B | |
| 20.99x | 2.3x | 11.62x | 1.59% | 22.34B | |
| 28.91x | 5.33x | 22.48x | 2.41% | 19.8B | |
| 7.62x | 1.22x | 5.77x | -.--% | 16.57B | |
| 16.03x | 1.5x | 7.65x | 4.38% | 15.58B | |
| 15.84x | 1.82x | 8.75x | 0.72% | 14.87B | |
| 13.97x | 1.03x | 5.8x | 3.28% | 12.8B | |
| Average | 16.16x | 1.86x | 9.90x | 2.05% | 34.81B | |
| Weighted average by Cap. | 15.84x | 1.39x | 9.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 8037 Stock
- Valuation China Biotech Services Holdings Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
